Neurim has been allowed to continue its case in the UK, in which it is seeking an injunction against Defendant Myla… https://t.co/1pmIv96OND

We are looking forward to our IP Strategy Beyond Drafting Patents event tomorrow, the second in our Healthcare Inno… https://t.co/ovtwiWOAN6